Strategic Overview
Ustar is a Chinese diagnostics company developing near-point-of-care molecular tests for TB diagnosis and drug resistance testing.
Innovation Portfolio
PortNAT TB
Portable nucleic acid amplification test for rapid MTBC detection from sputum or oral swabs. Designed for decentralized TB diagnosis with minimal equipment.
Molecular
Swab/Sputum
MultiNAT MTB/RIF
Portable nucleic acid amplification test for MTBC and rifampicin resistance detection. Supports multiple sample types with simplified workflow for primary care use.
Molecular
Various
Key Milestones
PortNAT TB nPOC molecular test
MultiNAT MTB/RIF drug resistance test
Commercial availability
High sensitivity (88.89%+ for TB, 100% for RIF)